Bionomics is a fully integrated, international drug discovery and development company creating new therapies that serve large unmet needs in cancer and central nervous system (CNS) disorders. Based in Adelaide, Australia with operations in San Diego, USA and a wholly owned subsidiary in Strasbourg, France, Bionomics is listed on the Australian Securities Exchange (ASX) under the code BNO, and the US OTCQX market under the code BNOEF.

ASX Announcements

  • Bionomics 2017/2018 Preliminary Final Results

    16 August 2018

    Download PDF

  • Full Year Statutory Accouts

    16 August 2018

    Download PDF

  • Bionomics Presents at the 14th Annual Bioshares Biotech Summit

    27 July 2018

    Download PDF

LATEST CORPORATE PRESENTATION

Latest Analyst Report